Caladrius Biosciences Inc (NASDAQ:CLBS)

1.87
Delayed Data
As of 12:52pm ET
 -0.007 / -0.37%
Today’s Change
1.80
Today|||52-Week Range
7.22
-50.32%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Caladrius Biosciences Inc have a median target of 12.00, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +540.68% increase from the last price of 1.87.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Caladrius Biosciences Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.41
Sales
$4.7M
Reporting Date
Aug 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 20.59%
 
 
 
 
 
 
Growthannually 5.79%
 
 
 
 
 
 

Sales

Growthquarterly 48.16%
 
 
 
 
 
 
Growthannually 20.01%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account